Cargando…
YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
BACKGROUND: Genomic rearrangements involving the ETS family of transcription factors occur in 40–70% of prostate cancer cases. ERG and ETV1 are the most common ETS members observed in these genetic alterations. The high prevalence of these rearrangements and their biological significance represents...
Autores principales: | Rahim, Said, Beauchamp, Elspeth M., Kong, Yali, Brown, Milton L., Toretsky, Jeffrey A., Üren, Aykut |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084826/ https://www.ncbi.nlm.nih.gov/pubmed/21559405 http://dx.doi.org/10.1371/journal.pone.0019343 |
Ejemplares similares
-
A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model
por: Rahim, Said, et al.
Publicado: (2014) -
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
por: Barber-Rotenberg, Julie S., et al.
Publicado: (2012) -
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
por: Minas, Tsion Zewdu, et al.
Publicado: (2015) -
The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer
por: Yu, Lin, et al.
Publicado: (2017) -
Synthesis and Structure–Activity
Relationship
Studies of Small Molecule Disruptors of EWS-FLI1 Interactions in Ewing’s
Sarcoma
por: Tosso, Perrer N., et al.
Publicado: (2014)